Staten Biotechnology statenbiotech.com


Staten Biotechnology develops technology and strategies for the prevention of cardiovascular events. Staten develops a human monoclonal antibody with an approach towards neutralizing apoC3 - a molecule in dyslipidemia managemen - which reduces triglyceride levels and increases the removal of atherogenic lipoprotein remnant particles.

Staten Biotechnology develops technology and strategies for the prevention of cardiovascular events. Staten develops a human monoclonal antibody with an approach towards neutralizing apoC3 - a molecule in dyslipidemia managemen - which reduces trigly...Show all

Company (Alive / Active)

Phone: +31 357606500

Fax:

Transistorweg 5J

Nijmegen, 6534
Netherlands

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Staten Biotechnology $0M Apr 22, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Staten Biotechnology Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Forbion Capital PartnersVenture CapitalNaarden, NetherlandsOther Investors
BioGeneration VenturesVenture CapitalNaarden, NetherlandsOther Investors
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)